(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 1.19% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 0.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.67%.
Innospec's revenue in 2025 is $1,873,300,000.On average, 2 Wall Street analysts forecast IOSP's revenue for 2025 to be $47,276,795,218, with the lowest IOSP revenue forecast at $46,117,011,004, and the highest IOSP revenue forecast at $48,436,579,432.
In 2026, IOSP is forecast to generate $48,259,494,100 in revenue, with the lowest revenue forecast at $48,259,494,100 and the highest revenue forecast at $48,259,494,100.